Persephone’s mission is to unlock the potential of the gut microbiome to develop equitable precision medicine.
Why equitable precision medicine?
Cancer death rates vary significantly amongst different ethnic and racial groups.
To develop effective precision medicine for all, clinical studies are needed that accurately map disease at the population-scale, thereby reducing health disparities.
Cancer Deaths per Year*
*Per 100,000 Persons by Race/Ethnicity, both Sexes: All Cancers. www.SEER.cancer.gov
Why equitable precision medicine?
Cancer death rates vary significantly amongst different ethnic and racial groups. To develop effective precision medicine for all, clinical studies are needed that accurately map disease at the population-scale, thereby reducing health disparities.
Cancer Deaths per Year*
*Per 100,000 Persons by Race/Ethnicity, both Sexes: All Cancers. www.SEER.cancer.gov
The ARGONAUT Study
ARGONAUT is a longitudinal, prospective, observational study that will enroll up to 4,000 advanced-stage cancer patients of diverse racial backgrounds to collect data used to develop precision microbiome medicines and for the identification of companion diagnostics to guide therapeutic decisions.
The ARGONAUT Study
ARGONAUT is a longitudinal, prospective, observational study that will enroll up to 4,000 advanced-stage cancer patients of diverse racial backgrounds to collect data used to develop precision microbiome medicines and for the identification of companion diagnostics to guide therapeutic decisions.
Persephone’s approach
We are leading a paradigm shift in medicine by using real-world patient data, augmented intelligence, and synthetic biology to develop equitable precision medicines for the gut microbiome.
Persephone’s approach
We are leading a paradigm shift in medicine by using real-world patient data, augmented intelligence, and synthetic biology to develop equitable precision medicines for the gut microbiome.
To achieve this, we have built a platform that is based on population-scale observational clinical trials, advanced genomics and immunology techniques, and machine learning to understand the impact of gut microbes on patient prognosis and immune system function.
